SIONSionna Therapeutics, Inc.

Healthcare
$51.04+193% 1Y

The financials

Sionna Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 4, 2026, the same week as a year ago.

Sionna Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$32M−$22Mn/a
Net income−$30M−$18Mn/a
Diluted EPS−$0.66−$410.00n/a
On our screens:Most shorted stocks

Biotechnology

The closest names by size in the same industry

Compare peers
VRDN+1.7%
Viridian Therapeutics, Inc.
PVLA+5.7%
Palvella Therapeutics, Inc.
LKFT+0.78%
Lakefront Biotherapeutics NV
PGEN+3.0%
Precigen, Inc.
STOK+3.3%
Stoke Therapeutics, Inc.
HRMY+1.7%
Harmony Biosciences Holdings, Inc.